Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study

Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study

Pulmonary hypertension is frequently underdiagnosed, and referral is delayed with subsequent impact on outcomes. During the SARS-CoV-2 pandemic, restrictions on daily life and changes in hospitals' daily routine care were introduced in Germany. This multi-centre study provides evidence for a ne...

Full description

Bibliographic Details
Main Authors:	Athiththan Yogeswaran, Henning Gall, Khodr Tello, Ekkehard Grünig, Panagiota Xanthouli, Ralf Ewert, Jan C. Kamp, Karen M. Olsson, Max Wißmüller, Stephan Rosenkranz, Hans Klose, Lars Harbaum, Tobias J. Lange, Christian F. Opitz, Andrea Waelde, Katrin Milger, Natascha Sommer, Werner Seeger, Hossein Ardeschir Ghofrani, Manuel J. Richter
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-07-01
Series:	Pulmonary Circulation
Online Access:	https://doi.org/10.1177/2045894020941682

Similar Items

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
by: Athiththan Yogeswaran, et al.
Published: (2020-10-01)

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension
by: Jan Grimminger, et al.
Published: (2017-01-01)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
by: Henning Gall, et al.
Published: (2021-04-01)

The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.
by: Manuel Jonas Richter, et al.
Published: (2016-01-01)

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.
by: Manuel Jonas Richter, et al.
Published: (2016-01-01)

Physical Activity and Mental Health of Patients with Pulmonary Hypertension during the COVID-19 Pandemic
by: Carolin Leoni Dobler, et al.
Published: (2020-12-01)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
by: Manuel J. Richter, et al.
Published: (2019-09-01)

Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
by: Manuel J. Richter, et al.
Published: (2020-03-01)

Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension
by: Dirk Bandorski, et al.
Published: (2016-01-01)

Right ventricular dyssynchrony: from load-independent right ventricular function to wall stress in severe pulmonary arterial hypertension
by: Manuel J. Richter, et al.
Published: (2020-05-01)

N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.
by: Lars Harbaum, et al.
Published: (2014-01-01)

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and <it>BMPR2 </it>mutations
by: Tiede Henning, et al.
Published: (2011-07-01)

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)
by: Hossein-Ardeschir Ghofrani, et al.
Published: (2020-07-01)

Electrophysiological Studies in Patients with Pulmonary Hypertension: A Retrospective Investigation
by: Dirk Bandorski, et al.
Published: (2014-01-01)

Right Heart Size and Right Ventricular Reserve in Pulmonary Hypertension: Impact on Management and Prognosis
by: Ekkehard Grünig, et al.
Published: (2020-12-01)

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up
by: Panagiota Xanthouli, et al.
Published: (2020-05-01)

Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives
by: Faeq Husain‐Syed, et al.
Published: (2021-02-01)

Practical management of riociguat in patients with pulmonary arterial hypertension
by: Michael Halank, et al.
Published: (2019-08-01)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
by: Alberto M. Marra, et al.
Published: (2018-12-01)

New horizons in pulmonary arterial hypertension therapies
by: Nazzareno Galiè, et al.
Published: (2013-12-01)

The role of combination therapy in managing pulmonary arterial hypertension
by: Hossein-Ardeschir Ghofrani, et al.
Published: (2014-12-01)

Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study
by: Gérald Simonneau, et al.
Published: (2020-12-01)

Imaging the heart in pulmonary hypertension: an update
by: Ekkehard Grünig, et al.
Published: (2015-12-01)

Zur Rolle der schwannzell-assoziierten Zelladhäsionsmoleküle NrCAM und L1CAM in der neuralen Karzinomzellinvasion im Pankreaskarzinom
by: Klose, Natascha
Published: (2013)

De la maternité à l’infanticide : la construction de la figure maternelle dans la mythologie grecque
by: Xanthouli, Paraskevi
Published: (2018)

Cardiovocal Syndrome (Ortner's Syndrome) Associated with Chronic Thromboembolic Pulmonary Hypertension and Giant Pulmonary Artery Aneurysm: Case Report and Review of the Literature
by: Jaakko Heikkinen, et al.
Published: (2012-01-01)

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension—A Genetic Study
by: Christina A. Eichstaedt, et al.
Published: (2020-05-01)

Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study
by: Lukas Fischer, et al.
Published: (2018-11-01)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
by: Weissmann Norbert, et al.
Published: (2005-07-01)

Follow-Up (Measurement) of Corrected QT Interval in Adult Patients before and after Lung Transplantation
by: Dirk Bandorski, et al.
Published: (2017-01-01)

Copyright and the Internet : closing the gates on the public domain
by: Waelde, Charlotte
Published: (2002)

Endoscopic lung volume reduction coil treatment in patients with chronic hypercapnic respiratory failure: an observational study
by: Marcel Simon, et al.
Published: (2017-01-01)

Endoscopic lung volume reduction coil treatment in patients with very low FEV: an observational study
by: Marcel Simon, et al.
Published: (2018-02-01)

Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
by: R. James White, et al.
Published: (2019-09-01)

Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension
by: N Sommer, et al.
Published: (2018-11-01)

Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension
by: Da Hee Park, et al.
Published: (2021-06-01)

Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
by: Mareike Gierhardt, et al.
Published: (2021-09-01)

Medical management of chronic thromboembolic pulmonary hypertension
by: Joanna Pepke-Zaba, et al.
Published: (2017-03-01)

Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model
by: Argen Mamazhakypov, et al.
Published: (2021-08-01)

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension
by: Djuro Kosanovic, et al.
Published: (2019-07-01)

Cannot write session to /tmp/vufind_sessions/sess_jv3bt28htkc4hpvhji5qi0jv7k